Frontlight ResearchEarly access
TerminatedNo phase
Ultrasound Detection and Characterization of Subclinical Hypertrophy in Diabetes
Key facts
- Who runs it
- University of British Columbia
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 100 people enrolled
- Started
- Mar 2015
- Ended
- 22 Apr 2025
- Type of study
- Observational
- Treatments tested
- Ultrasound
- Record updated
- 7 May 2025
- Why it stopped
- The study run its course
Who can take part
- Age
- 19 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- 19 years of age or older
- Type 1 or Type 2 diabetes
- Using insulin to manage diabetes for at least 2 years
Who cannot take part
- Using insulin pumps, insulin secretagogues, Glucagon-Like Peptide-1 (GLP-1) agonists to manage diabetes
- Use of immunosuppressant agents
- Women who are pregnant
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a pilot study to enroll 100 people to assess the incidence of lipohypertrophy as detected with ultrasound and its impact on glycemic variability.
Treatments tested
- Ultrasound
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Ultrasound Guided Detection and Characterization of Subclinical Lipohypertrophy in Type 1 and Type 2 Diabetes Mellitus
- Publications
- Ultrasound detection of insulin-induced lipohypertrophy in Type 1 and Type 2 diabetes.Diabetic medicine : a journal of the British Diabetic Association, 2018
- Record updated
- 7 May 2025